Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
14 Total results for product and free and sample content found
Trial Results Summaries
19 Apr 2021
Trial Results Summaries provides an unbiased and non-promotional portal for sponsors to share trial results summaries, also known as plain language summaries (PLS), with participants and the public.
Topic Clinical Trials
Trial Results Summaries
19 Apr 2021
What Are Trial Results Summaries and Why Are They Necessary?
Topic Clinical Trials
Trial Transparency Website
16 Apr 2021
With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure
Topic Clinical Trials
Sitetrove, Trialtrove
01 Dec 2020
Even one misstep in your clinical trials strategy or execution can cost your company millions. Save time and cost with the trusted source for global investigator and site intelligence and global pharmaceutical clinical trial intelligence by subscribing to Sitetrove and Trialtrove.
Topic Clinical Trials Coronavirus
By Pharma Intelligence 27 Nov 2020
A recent survey found 44% of investigators anticipate COVID-19 having a negative impact on their future ability to enroll patients in clinical trials. The adoption of virtual/decentralized trials on a larger, global scale will make the recruitment of patients more complex. To avoid the risk of failure, Citeline Engage can help you recruit experienced investigators with known patient pools and specialized physicians in proximity to support patient referrals.
Topic Clinical Trials
Skipta
24 Jul 2020
With the COVID-19 pandemic raging, verified HCPs are turning to Skipta more than ever to access clinically relevant information reaching beyond the crisis. Find out how other brand managers engaged these members using Skipta’s disease-specific micro-communities.
Topic Neurology Market Intelligence
By Pharma Intelligence 03 Sep 2018
The Issue Our client asked us to help support their CNS product portfolio strategy by helping to understand the clinical and commercial potential of the schizophrenia market
11 Sep 2017
The Issue: A global pharmaceutical company needed to assess the current and future competitive landscape of an early-stage analog drug to determine the possibilities of market entry and the viability of possible differentiation strategies to compete in the market.
11 Sep 2017
The Issue: Our client wished to understand the potential impact of the competitor’s drug going generic on their brand and whether there would be any spill-over effects.
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
